PTC Therapeutics Inc (NASDAQ:PTCT)

26.23
Delayed Data
As of Apr 20
 +0.13 / +0.50%
Today’s Change
10.65
Today|||52-Week Range
33.22
+57.25%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 28.00, with a high estimate of 35.00 and a low estimate of 15.00. The median estimate represents a +6.75% increase from the last price of 26.23.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.69
Sales
$59.2M
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2,411.21%
 
 
 
 
 
 
Growthannually 57.64%
 
 
 
 
 
 

Sales

Growthquarterly -24.09%
 
 
 
 
 
 
Growthannually 44.33%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.